123 related articles for article (PubMed ID: 16201909)
41. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC
Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
[TBL] [Abstract][Full Text] [Related]
42. [Detection of KatG 315 gene mutation associated with isoniazid resistance in Mycobacterium tuberculosis by template-directed dye-terminator incorporation with fluorescence polarization detection technology].
Wang Y; Zhang WH; Zhao JR; Luo M; Zhang ZX; Bai YJ; Yan XJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Mar; 27(3):179-82. PubMed ID: 15130329
[TBL] [Abstract][Full Text] [Related]
43. Pyrazinamide is not active against Mycobacterium tuberculosis residing in cultured human monocyte-derived macrophages.
Heifets L; Higgins M; Simon B
Int J Tuberc Lung Dis; 2000 Jun; 4(6):491-5. PubMed ID: 10864178
[TBL] [Abstract][Full Text] [Related]
44. Proteome-wide lysine acetylation profiling of the human pathogen Mycobacterium tuberculosis.
Xie L; Wang X; Zeng J; Zhou M; Duan X; Li Q; Zhang Z; Luo H; Pang L; Li W; Liao G; Yu X; Li Y; Huang H; Xie J
Int J Biochem Cell Biol; 2015 Feb; 59():193-202. PubMed ID: 25456444
[TBL] [Abstract][Full Text] [Related]
45. Applications of Ensemble Docking in Potential Inhibitor Screening for Mycobacterium tuberculosis Isocitrate Lyase Using a Local Plant Database.
Lee YV; Choi SB; Wahab HA; Lim TS; Choong YS
J Chem Inf Model; 2019 May; 59(5):2487-2495. PubMed ID: 30840452
[TBL] [Abstract][Full Text] [Related]
46. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis.
Höner Zu Bentrup K; Miczak A; Swenson DL; Russell DG
J Bacteriol; 1999 Dec; 181(23):7161-7. PubMed ID: 10572116
[TBL] [Abstract][Full Text] [Related]
47. Antimicrobial antibodies by phage display: Identification of antibody-based inhibitor against mycobacterium tuberculosis isocitrate lyase.
Ch'ng ACW; Schepergerdes L; Choong YS; Hust M; Lim TS
Mol Immunol; 2022 Oct; 150():47-57. PubMed ID: 35987135
[TBL] [Abstract][Full Text] [Related]
48. The extreme sensitivity of Mycobacterium tuberculosis to the front-line antituberculosis drug isoniazid.
Deretic V; Pagán-Ramos E; Zhang Y; Dhandayuthapani S; Via LE
Nat Biotechnol; 1996 Nov; 14(11):1557-61. PubMed ID: 9634820
[TBL] [Abstract][Full Text] [Related]
49. IQG-607 abrogates the synthesis of mycolic acids and displays intracellular activity against Mycobacterium tuberculosis in infected macrophages.
Rodrigues-Junior VS; dos Santos Junior AA; Villela AD; Belardinelli JM; Morbidoni HR; Basso LA; Campos MM; Santos DS
Int J Antimicrob Agents; 2014 Jan; 43(1):82-5. PubMed ID: 24139881
[TBL] [Abstract][Full Text] [Related]
50. [A study on in vitro and in vivo models of Mycobacterium tuberculosis persistence].
Lu Y; Gao MQ; Zhao WJ; Wang B; Ma LP; Zhu LZ
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):211-5. PubMed ID: 17573002
[TBL] [Abstract][Full Text] [Related]
51. Innate cytokine profiling of bovine alveolar macrophages reveals commonalities and divergence in the response to Mycobacterium bovis and Mycobacterium tuberculosis infection.
Magee DA; Conlon KM; Nalpas NC; Browne JA; Pirson C; Healy C; McLoughlin KE; Chen J; Vordermeier HM; Gormley E; MacHugh DE; Gordon SV
Tuberculosis (Edinb); 2014 Jul; 94(4):441-50. PubMed ID: 24882682
[TBL] [Abstract][Full Text] [Related]
52. A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis.
Ando H; Miyoshi-Akiyama T; Watanabe S; Kirikae T
Mol Microbiol; 2014 Feb; 91(3):538-47. PubMed ID: 24354762
[TBL] [Abstract][Full Text] [Related]
53. Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor.
Sriram D; Yogeeswari P; Methuku S; Vyas DR; Senthilkumar P; Alvala M; Jeankumar VU
Bioorg Med Chem Lett; 2011 Sep; 21(18):5149-54. PubMed ID: 21840711
[TBL] [Abstract][Full Text] [Related]
54. Usefulness of acr expression for monitoring latent Mycobacterium tuberculosis bacilli in 'in vitro' and 'in vivo' experimental models.
Gordillo S; Guirado E; Gil O; Díaz J; Amat I; Molinos S; Vilaplana C; Ausina V; Cardona PJ
Scand J Immunol; 2006 Jul; 64(1):30-9. PubMed ID: 16784488
[TBL] [Abstract][Full Text] [Related]
55. Mechanism-based inactivator of isocitrate lyases 1 and 2 from
Pham TV; Murkin AS; Moynihan MM; Harris L; Tyler PC; Shetty N; Sacchettini JC; Huang HL; Meek TD
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7617-7622. PubMed ID: 28679637
[TBL] [Abstract][Full Text] [Related]
56. Alternate pathway to ascorbate induced inhibition of Mycobacterium tuberculosis.
Shukla H; Khan SR; Shukla R; Krishnan MY; Akhtar MS; Tripathi T
Tuberculosis (Edinb); 2018 Jul; 111():161-169. PubMed ID: 30029903
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of Mycobacterium tuberculosis secretory serine protease blocks bacterial multiplication both in axenic culture and in human macrophages.
Upadhye V; Majumdar A; Gomashe A; Joshi D; Gangane N; Thamke D; Mendiratta D; Harinath BC
Scand J Infect Dis; 2009; 41(8):569-76. PubMed ID: 19479636
[TBL] [Abstract][Full Text] [Related]
58. Activity loss by H46A mutation in Mycobacterium tuberculosis isocitrate lyase is due to decrease in structural plasticity and collective motions of the active site.
Shukla R; Shukla H; Tripathi T
Tuberculosis (Edinb); 2018 Jan; 108():143-150. PubMed ID: 29523315
[TBL] [Abstract][Full Text] [Related]
59. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical strains isolated in the Philippines.
Herrera L; Valverde A; Saiz P; Sáez-Nieto JA; Portero JL; Jiménez MS
Int J Antimicrob Agents; 2004 Jun; 23(6):572-6. PubMed ID: 15194127
[TBL] [Abstract][Full Text] [Related]
60. A systems chemical biology study of malate synthase and isocitrate lyase inhibition in Mycobacterium tuberculosis during active and NRP growth.
May EE; Leitão A; Tropsha A; Oprea TI
Comput Biol Chem; 2013 Dec; 47():167-80. PubMed ID: 24121675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
